Leef Brands (LEEEF) Prepaid Assets (2024 - 2026)

Leef Brands (LEEEF) reported Prepaid Assets of $1.3 million for Q1 2026, up 149.25% sequentially from $505438.0 in Q4 2025.

Leef Brands (LEEEF) Prepaid Assets (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Prepaid Assets data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets changed N/A year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (changed N/A YoY), and the FY2025 full-year result was $505438.0, down 18.68% from the prior year.
  • Prepaid Assets rose to $1.3 million in Q1 2026, from $505438.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.3 million in Q1 2026 to a low of $505438.0 in Q4 2025.
  • A 3-year average of $795590.3 and a median of $621527.0 in 2024 frame the typical range for Prepaid Assets.
  • Peak annual rise in Prepaid Assets reached 18.68% in 2025, while the deepest fall reached 18.68% in 2025.
  • Tracing LEEEF's Prepaid Assets over 3 years: stood at $621527.0 in 2024, then declined by 18.68% to $505438.0 in 2025, then soared by 149.25% to $1.3 million in 2026.
  • Business Quant data shows LEEEF's Prepaid Assets at $1.3 million in Q1 2026, $505438.0 in Q4 2025, and $621527.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.26 Mn
Dec 31, 2025 505,438.00
Dec 31, 2024 621,527.00